1. van Veen JJ, Spahn DR, Makris M. Routine preoperative coagulation tests: an outdated practice? Br J Anaesth 2011; 106: 1–3.
2. Mulloy B, Hogwood J, Gray E, Lever R, Page CP. Pharmacology of Heparin and Related Drugs. Pharmacol Rev. 2016 Jan;68(1):76-141. doi: 10.1124/pr.115.011247. PMID: 26672027.
3. Talari G, Demertzis ZD, Summey RD, et al. Perioperative management of anticoagulation. Hosp Pract (1995) 2020; 48: 231–240.
4. Hull RD, Garcia A, Vazquez SR. Biology of warfarin and modulators of INR control. Wolters Kluwer, 2022.
5. Polania Gutierrez JJ, Rocuts KR. Perioperative Anticoagulation Management. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK557590/
6. U.S. Food and Drug Administration (FDA). Heparin. FDA, 2006. https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017037s158lbl.pdf
7. Clinical Excellence Commission. Guidelines on perioperative management of anticoagulant and antiplatelet agents. 2018.
8. Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW. Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. J Med Toxicol. 2011 Dec;7(4):281-7. doi: 10.1007/s13181-011-0178-y. PMID: 21887485; PMCID: PMC3550194.
9. Horlocker TT, Vandermeuelen E, Kopp SL, et al. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition). 2018. Epub ahead of print 2018. DOI: 10.1097/AAP.0000000000000763.
10. Mueck W, Stampfuss J, Kubitza D, et al. Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban. Clin Pharmacokinet 2014; 53: 1–16.
11. Teng R. Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update. Clin Pharmacokinet 2015; 54: 1125–1138.
12. Lassila R. Clinical Use of Factor XIII Concentrates. Semin Thromb Hemost. 2016 Jun;42(4):440-4. doi: 10.1055/s-0036-1572324. Epub 2016 Apr 12. PMID: 27071044.
13. Dutta TK, Verma SP. Rational Use of Recombinant Factor VIIa in Clinical Practice. Indian J Hematol Blood Transfus. 2014 Jun;30(2):85-90. doi: 10.1007/s12288-013-0240-9. Epub 2013 Feb 23. PMID: 24839361; PMCID: PMC4022918.
14. Drugs and Lactation Database. Bethesda (MD): National Library of Medicine (US); 2019-. Coagulation Factor X. https://www.ncbi.nlm.nih.gov/books/NBK500890/
15. Drugs and Lactation Database. Bethesda (MD): National Library of Medicine (US); 2018-. Coagulation Factor IX. https://www.ncbi.nlm.nih.gov/books/NBK500892/
16. Bonhomme F, Boehlen F, Clergue F, et al. Évaluation préopératoire de l’hémostase: un nouveau questionnaire simple sur le saignement. Can J Anesth 2016; 63: 1007–1015.
17. Alzahrani A, Othman N, Bin-Ali T, et al. Routine Preoperative Coagulation Tests in Children Undergoing Elective Surgery or Invasive Procedures: Are They Still Necessary? Clin Med Insights Blood Disord; 12. Epub ahead of print 1 January 2019. DOI: 10.1177/1179545X18821158.
18. Cook BW. Anticoagulation management. Semin Intervent Radiol. 2010 Dec;27(4):360-7. doi: 10.1055/s-0030-1267849. PMID: 22550377; PMCID: PMC3324206.
19. Thiruvenkatarajan V, Pruett A, Adhikary SD. Coagulation testing in the perioperative period. Indian J Anaesth. 2014 Sep;58(5):565-72. doi: 10.4103/0019-5049.144657. PMID: 25535418; PMCID: PMC4260302.
20. Russeau AP, Vall H, Manna B. Bleeding Time. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK537233/
21. Yang R, Moosavi L. Prothrombin Time. [Updated 2022 Mar 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544269/
22. Rountree KM, Yaker Z, Lopez PP. Partial Thromboplastin Time. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK507772/
23. Karapetian H. Reptilase time (RT). Methods Mol Biol. 2013;992:273-7. doi: 10.1007/978-1-62703-339-8_20. PMID: 23546720.
24. Hutt Centeno E, Militello M, Gomes MP. Anti-Xa assays: What is their role today in antithrombotic therapy? Cleve Clin J Med. 2019 Jun;86(6):417-425. doi: 10.3949/ccjm.86a.18029. PMID: 31204981.
25. Kaur J, Jain A. Fibrinogen. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK537184/
26. Bounds EJ, Kok SJ. D Dimer. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK431064/
27. Polania Gutierrez JJ, Rocuts KR. Perioperative Anticoagulation Management. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK557590/
28. Horton S, Augustin S. Activated clotting time (ACT). Methods Mol Biol. 2013;992:155-67. doi: 10.1007/978-1-62703-339-8_12. PMID: 23546712.
29. Atallah S, Liebl M, Fitousis K, Bostan F, Masud F. Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients. Perfusion. 2014 Sep;29(5):456-61. doi: 10.1177/0267659114524264. Epub 2014 Feb 25. PMID: 24570077.
30. Solari F, Varacallo M. Low Molecular Weight Heparin (LMWH). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK525957/
31. Schlitt A, Jámbor C, Spannagl M, Gogarten W, Schilling T, Zwissler B. The perioperative management of treatment with anticoagulants and platelet aggregation inhibitors. Dtsch Arztebl Int. 2013 Aug;110(31-32):525-32. doi: 10.3238/arztebl.2013.0525. Epub 2013 Aug 5. PMID: 24069073; PMCID: PMC3782019.
32. Huang MJ, Wei RB, Wang Y, Su TY, Di P, Li QP, Yang X, Li P, Chen XM. Blood coagulation system in patients with chronic kidney disease: a prospective observational study. BMJ Open. 2017 Jun 1;7(5):e014294. doi: 10.1136/bmjopen-2016-014294. PMID: 28576889; PMCID: PMC5541338.